Therapure BioPharma Inc
From Wikipedia, the free encyclopedia
Company typeBiotechnology
IndustryBiopharmaceutical, Biomanufacturing, biotechnology
Founded2008
HeadquartersMississauga, Ontario, Canada
 | |
| Company type | Biotechnology |
|---|---|
| Industry | Biopharmaceutical, Biomanufacturing, biotechnology |
| Founded | 2008 |
| Headquarters | Mississauga, Ontario, Canada |
Key people | Nicholas Green (CEO), Rajan Puri (Director) |
| Products | Therapeutic Proteins[1][2] |
Number of employees | 300 |
| Website | http://www.therapurebio.com |
Therapure BioPharma, Inc. is a Canadian biopharmaceutical industry and biotechnology company, headquartered in Mississauga, Ontario, a privately held, integrated Contract Development and Manufacturing Organization (CDMO). Founded in 2008, the firm provides a range of therapeutic protein development and manufacturing services including; technology transfer & process development, analytical development and testing, scale up and cGMP manufacturing, and aseptic fill/finish and lyophilization. As of 2010[update], the company has over 90 employees.[3] In 2020, Therapure was acquired by Resilience.[4]
